U.S. doctors target sugary drinks bought by government

By Madeline Will NEW YORK (Reuters) – The American Medical Association joined the effort to discourage consumption of sugary drinks on Wednesday with a pledge to work to get them off U.S. government food aid programs for the poor. The nation’s largest physician group said removing the sugary beverages from the Supplemental Nutrition Assistance Program would help reduce weight-related health problems. “The AMA is working to improve the nation’s health care outcomes, particularly cardiovascular disease and diabetes, which are often linked to obesity,” said AMA President Dr. …

Deadly new coronavirus a "serious risk" in hospitals – Saudi study

A man, wearing a surgical mask as a precautionary measure against the novel coronavirus, walks near a hospital in Khobar city in DammamBy Kate Kelland LONDON (Reuters) – The new Middle East coronavirus that has killed 38 people after emerging late last year is a serious risk in hospitals because it is easily transmitted in healthcare environments, infectious disease experts said on Wednesday. In a study published in the New England Journal of Medicine, the researchers said the Middle East respiratory syndrome (MERS)was not only easily transmitted from patient to patient, but also from the transfer of sick patients to other hospitals. …

Nowhere to hide from diarrhea-causing bacteria: study

By Andrew M. Seaman NEW YORK (Reuters Health) – Otherwise healthy people with a diarrhea-causing infection may have picked up the bacteria in doctors’ offices or other healthcare sites, according to a new government study that also hints heartburn medications might increase the risk. Researchers from the U.S. Centers for Disease Control and Prevention (CDC) found that about 82 percent of Clostridium difficile, or C. diff, cases in healthy people occurred after visiting healthcare settings – like doctors’ offices and emergency rooms. “I think people should be aware of the source,” said Dr. …

Exclusive: Forest mulls bid for Irish drugmaker Elan – sources

By Jessica Toonkel and Soyoung Kim NEW YORK (Reuters) – Forest Laboratories Inc, the specialty drugmaker that counts investor Carl Icahn as a major shareholder, is among a handful of companies interested in bidding for Irish drugmaker Elan Corp Plc, two people familiar with the situation said. Elan, which has a market capitalization of nearly $7 billion, put itself up for sale last week in an effort to fend off a hostile offer from U.S. investment firm Royalty Pharma. Forest is among several mid-sized drugmakers considering an offer for Elan, the people said on Wednesday. …

1 31 32 33 34 35 101